Early Asset Management Lead Oncology (m/f/d)

For the “Early Asset Management” unit in the BPT sector, we are looking for an exceptionally qualified and experienced leader as Early Asset Management Lead (m/w/d) Oncology at our location in Hamburg. The newly created position plays a key role in the need analysis and prioritization of future oncology assets (Early Assets) and the establishment of multifunctional early asset squads. The aim is to optimally coordinate necessary activities in research, HTA, admission, market engagement and clinical introduction, in close interconnection with internal functions, stakeholders and global development programmes.

Your main objections: Coordination and management of multifunctional early asset squads - in close cooperation with Medical, Site Management & Monitoring (SM&M), Market Access, Diagnostics, Commercial, Corporate Affairs - to control AstraZeneca-internal and external early asset priorities, for example: establishment and implementation of strategy and transformation initiatives for important early assets Development and implementation of cross-functional plans and working processes for early assets that cover evidence generation, market design, forecasting and the preparation of market access, tailored to the German market requirements (e.g. HTA requirements, admission routes, market access dynamics). Designing the external ecosystem in Germany to enable the success of future products, including the development of advocacy strategies and plans to integrate stakeholders. Coordination of the operational priorities of the Early Asset Squad with the requirements of the German and global franchise Moderation of cross-functional workshops and strategic discussions (e.g. patient journey mapping, forecasting, competitive analysis).

In line with our Medical and SM&M teams, supporting the development and maintenance of strong relationships with: internal regional and global teams to prioritise important early assets for the German market and to establish more Phase-1 clinical studies at German clinics External stakeholders (e.g. treatment centres, forekeepers, policy makers and actors in the field of access to medicines) to conduct such phase-1 studies, anticipate market developments and support early introduction

Cooperation with global teams to strengthen Germany's role and visibility in the development of new active ingredients and the generation of evidence. Establishing processes and working methods to find early assets with influential evidence profiles and high importance for the German market

What you will play in: Passionate efforts to actively shape our leadership in cancer medicine in Germany, Europe and the world and thus generate substantial added value for patients, healthcare and AstraZeneca Completed studies in business, natural sciences or comparable; ideally additional qualification (Master, Promotion, MBA) At least 5 years of experience in oncology and/or hematology are presumed; ideally, experience with novel therapy methods (e.g. radio ligand therapies, cell therapies) At least 7 years of experience in strategic, cross-functional roles within the pharmaceutical industry Global mindset with excellent understanding of trends and parameters of global research, development and commercialization of biotechnological medical devices Experience in the areas of early development, market access or evidence generation Confidence with the German health system, HTA processes and access landscape Proven ability to manage and coordinate complex initiatives with several stakeholders Comprehensive experience in cross-functional cooperation in matrix organisations Visionary, targeted and pragmatic personality as well as high self-motivation, curiosity and will for personal development Excellent communication and presentation skills Safe for negotiation in German and English

What gives you this role You contribute to an organization that demonstrates its ability to transform cancer care and is ready to raise its significant impact on cancer patients to the next level. You have the opportunity to establish new therapies of tomorrow today and thus become an active architect of our common progress. You operate with a variety of stakeholders, customers and units, which allows you to significantly expand your experience in early asset workflow, portfolio, and life cycle management. You will be able to track a variety of career opportunities through exposure that affects all important parts of your different organizational functions. You work with highly committed and passionate people, driven by a deep commitment and goal.

It offers: an attractive pipeline and innovative products individual development opportunities and the focus on lifelong learning lots of trust, appreciation and space for co-design in a focused and passionate team, with regional, nationwide and international exposure Office space in the heart of Hamburg, which enables collaborative, flexible and agile cooperation a diverse, inclusive and prejudice-free working environment, committed to the Charter of Diversity, not only allows differences, but actively promotes and welcomes and takes into account applications from all qualified applicants, regardless of their characteristics a sustainable company that becomes CO2 negative by 2030 along the entire value chain an attractive benefit package such as EGYM Wellpass, Corporate Benefits and much more